SCHEMBL3678027

SCHEMBL3678027

CCCCC=CC1C(C(=O)O)C1(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 2/20 0.42
F3 P13726 2/20 0.42
PPARG P37231 5/20 0.38
PPARD Q03181 4/20 0.38
PPARA Q07869 4/20 0.38
TERT O14746 3/20 0.38
PTPN1 P18031 3/20 0.38
MAPT P10636 3/20 0.38
BLM P54132 3/20 0.38
HSD17B10 Q99714 3/20 0.38
FABP4 P15090 3/20 0.38
TOP1 P11387 3/20 0.38
USP2 O75604 2/20 0.38
LMNA P02545 2/20 0.38
ALOX15 P16050 2/20 0.38
RECQL P46063 2/20 0.38
CYP19A1 P11511 2/20 0.38
NR4A2 P43354 2/20 0.38
KMT2A Q03164 2/20 0.38
TDP1 Q9NUW8 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3678023 1.00 F7 (0.42) F7F3PPARGPPARDPPARA
SCHEMBL11500756 0.95 PPARG (0.44) F7F3PPARGPPARDPPARA
SCHEMBL11500757 0.95 PPARG (0.44) F7F3PPARGPPARDPPARA
Hydrochloric Acid SCHEMBL11162700 0.93 PPARG (0.43) F7F3PPARGPPARDPPARA
SCHEMBL11153266 0.93 TERT (0.47) F7F3PPARGPPARDPPARA
SCHEMBL11125710 0.93 TERT (0.47) F7F3PPARGPPARDPPARA
Hydrochloric Acid SCHEMBL11160682 0.92 TERT (0.46) F7F3PPARGPPARDPPARA
Hydrochloric Acid SCHEMBL11163279 0.87 LMNA (0.34) LMNA
SCHEMBL15977303 0.86 F7 (0.38) F7F3PPARGPPARDPPARA
SCHEMBL2168058 0.81 LMNA (0.41) F7F3LMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1832573-B1 Buret connections for rheology control BYK CHEMIE GMBH (DE) 2011-12-21 EP claimed
US-7655815-B2 Biuret compounds for rheology control BYK-CHEMIE GMBH (DE) 2010-02-02 US claimed
US-20070225451-A1 uretidone-containing compound from the reaction of a diisocyanate and alcohol; biuret derivative as end group for polyoxyethylene glycol;used in thixotroping coating systems for creep resistance and nonsettling properties; improved effect profile and improved reproducibility of thixotroping BYK-CHEMIE GMBH (DE) 2007-09-27 US claimed
CN-1934063-B Method for producing (2-formyl-1-alkenyl)cyclopropane compound SUMITOMO CHEMICAL CO 2010-12-15 CN disclosed
US-7700799-B2 Method for producing (2-formyl-1-alkenyl) cyclopropane compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-20 US disclosed
US-7655815-B2 Biuret compounds for rheology control BYK-CHEMIE GMBH (DE) 2010-02-02 US disclosed
US-20090137839-A1 METHOD FOR PRODUCING (2-FORMYL-1-ALKENYL) CYCLOPROPANE COMPOUND SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2009-05-28 US disclosed
US-7498459-B2 Method for producing (1-alkenyl)cyclopropane compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-03-03 US disclosed
US-20070197818-A1 Method for producing (1-alkenyl) cyclopropane compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-23 US disclosed
CN-1934063-A Method for producing (2-formyl-1-alkenyl)cyclopropane compound SUMITOMO CHEMICAL CO (JP) 2007-03-21 CN disclosed
EP-1728781-A1 PROCESS FOR PRODUCTION OF (1-ALKENYL)CYCLOPROPANES Sumitomo Chemical Company, Limited (JP) 2006-12-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137839-A1 METHOD FOR PRODUCING (2-FORMYL-1-ALKENYL) CYCLOPROPANE COMPOUND ACSL3, ACSL1, ARL1 F7 1360/4885F3 566/4885PPARG 2408/4885
US-20070197818-A1 Method for producing (1-alkenyl) cyclopropane compound ACSL3, ARL1, ACSL1 F7 2548/4885F3 876/4885PPARG 2780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.